Expression of transforming growth factor-α mRNA in livers of patients with chronic viral hepatitis and hepatocellular carcinoma
✍ Scribed by Young-Hwa Chung; Jeong A. Kim; Byung-Cheol Song; Geun Chan Lee; Moon Soo Koh; Yung Sang Lee; Seung Gyu Lee; Dong Jin Suh
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 109 KB
- Volume
- 89
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
✦ Synopsis
The authors thank Dr. Adrian M. Di Bisceglie for helpful suggestions and discussions and also for providing the plasmid-containing, full-length HBV-DNA.
📜 SIMILAR VOLUMES
BACKGROUND. Interferon (IFN) has been reported to have beneficial long term effects that reduce the occurrence of hepatocellular carcinoma (HCC), even in patients who do not have complete responses to IFN. The authors evaluated the effect of retreatment with IFN-␣ on the long term prognoses of those
Transforming growth factor-α (TGF-α) is a multifunctional cell regulatory protein with a wide range of effects on cell growth and differentiation and has been implicated in the neoplastic transformation of a variety of cell types. Altered expression of TGF-α and its cognate receptor (epidermal growt
## BACKGROUND. Transforming growth factors  (TGFs ) are involved in a variety of important cellular functions, including cell growth and differentiation, adhesion, migration, extracellular matrix formation, and immune function. Moreover, it has been reported that TGFs  are correlated with angiog
## BACKGROUND. To determine whether interferon (IFN) therapy can reduce incidence of the development of cirrhosis and hepatocellular carcinoma equally in patients with chronic hepatitis C virus (HCV) who responded differently to therapy, a retrospective analysis of 250 patients treated with IFN wa